Prurigo Nodularis (Incyte Corporation Study)
The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).
Trial available at the following locations:
Arizona,
View Trial
Arizona,